Optimizing the 6-min walk test as a measure of exercise capacity in COPD

Chest

Volumn 142, Issue 6, 2012, Pages 1545-1552

  Chandra, Divay ^a   Wise, Robert A ^b   Kulkarni, Hrishikesh S ^c   Benzo, Roberto P ^b   Criner, Gerard ^d   Make, Barry ^e   Slivka, William A ^a   Ries, Andrew L ^f   Reilly, John J ^c   Martinez, Fernando J ^g,h   Sciurba, Frank C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAYO CLINIC   (United States)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 MIN WALK TEST; ACCURACY; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; EMPHYSEMA; EXERCISE; FEMALE; FUNCTION TEST; FUNCTIONAL ASSESSMENT; HUMAN; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULMONARY REHABILITATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VALIDITY;

EID: 84870624079     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2702     Document Type: Article

References (44)

1. Salzman SH. The 6-min walk test: clinical and research role, technique, coding, and reimbursement. Chest. 2009;135(5):1345-1352.
2. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117.
3. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059-2073.
4. Patel SA, Sciurba FC. Emerging concepts in outcome assessment for COPD clinical trials. Semin Respir Crit Care Med. 2005;26(2):253-262. (Pubitemid 40617302)
5. McDermott MM, Ades P, Guralnik JM, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009;301(2):165-174.
6. King TE Jr, Behr J, Brown KK, et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2008;177(1):75-81.
7. Peurala SH, Tarkka IM, Pitkänen K, Sivenius J. The effectiveness of body weight-supported gait training and floor walking in patients with chronic stroke. Arch Phys Med Rehabil. 2005;86(8):1557-1564. (Pubitemid 41115817)
8. Duncan P, Studenski S, Richards L, et al. Randomized clinical trial of therapeutic exercise in subacute stroke. Stroke. 2003;34(9):2173-2180. (Pubitemid 37099832)
9. Andersson C, Asztalos L, Mattsson E. Six-minute walk test in adults with cerebral palsy. A study of reliability. Clin Rehabil. 2006;20(6):488-495. (Pubitemid 44102821)
10. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax. 1984;39(11):818-822. (Pubitemid 14022730)
11. Liu J, Drutz C, Kumar R, et al. Use of the six-minute walk test poststroke: is there a practice effect? Arch Phys Med Rehabil. 2008;89(9):1686-1692.
12. Pankoff BA, Overend TJ, Lucy SD, White KP. Reliability of the six-minute walk test in people with fibromyalgia. Arthritis Care Res. 2000;13(5):291-295.
13. Solway S, Brooks D, Lau L, Goldstein R. The short-term effect of a rollator on functional exercise capacity among individuals with severe COPD. Chest. 2002;122(1):56-65. (Pubitemid 34754143)
14. Wu G, Sanderson B, Bittner V. The 6-minute walk test: how important is the learning effect? Am Heart J. 2003;146(1):129-133. (Pubitemid 36851311)
15. Troosters T, Gosselink R, Decramer M. Six-minute walk test: a valuable test, when properly standardized. Phys Ther. 2002;82(8):826-827.
16. Ulrich S, Speich R, Domenighetti G, et al. Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study). Swiss Med Wkly. 2007;137(41-42):573-580.
17. Mutrie N, Campbell AM, Whyte F, et al. Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ. 2007;334(7592):517.
18. Miller JD, Malthaner RA, Goldsmith CH, et al Canadian Lung Volume Reduction Surgery Study. A randomized clinical trial of lung volume reduction surgery versus best medical care for patients with advanced emphysema: a two-year study from Canada. Ann Thorac Surg. 2006;81(1):314-320.
19. Gomberg-Maitland M, Tapson VF, Benza RL, et al. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Am J Respir Crit Care Med. 2005;172(12):1586-1589. (Pubitemid 43076550)
20. Gavin AD, Struthers AD. Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure. Heart. 2005;91(6):749-753. (Pubitemid 40769216)
21. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed). 1982;284(6329):1607-1608. (Pubitemid 12105148)
22. McGavin CR, Gupta SP, McHardy GJ. Twelve-minute walking test for assessing disability in chronic bronchitis. BMJ. 1976;1(6013):822-823.
23. Jenkins S, Cecins NM. Six-minute walk test in pulmonary rehabilitation: do all patients need a practice test? Respirology. 2010;15(8):1192-1196.
24. Sciurba F, Criner GJ, Lee SM, et al National Emphysema Treatment Trial Research Group. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med. 2003;167(11):1522-1527. (Pubitemid 37363362)
25. Larsson UE, Reynisdottir S. The six-minute walk test in out-patients with obesity: reproducibility and known group validity. Physiother Res Int. 2008;13(2):84-93.
26. Eisen EA, Letz RA, Wegman DH, Baker EL Jr, Pothier L. Defining measurement precision for effort dependent tests: the case of three neurobehavioural tests. Int J Epidemiol. 1988;17(4):920-926. (Pubitemid 19042041)
27. The National Emphysema Treatment Trial Research Group. Rationale and design of The National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. Chest. 1999;116(6):1750-1761.
28. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med. 1997;155(4):1278-1282. (Pubitemid 27172771)
29. Rostagno C, Gensini GF. Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure. Intern Emerg Med. 2008;3(3):205-212.
30. Starobin D, Kramer MR, Yarmolovsky A, et al. Assessment of functional capacity in patients with chronic obstructive pulmonary disease: correlation between cardiopulmonary exercise, 6 minute walk and 15 step exercise oximetry test. Isr Med Assoc J. 2006;8(7):460-463. (Pubitemid 44122023)
31. Cote CG, Pinto-Plata VM, Marin JM, Nekach H, Dordelly LJ, Celli BR. The modified BODE index: validation with mortality in COPD. Eur Respir J. 2008;32(5):1269-1274.
32. Steiger JH. Tests for comparing elements of a correlation matrix. Psychol Bull. 1980;87(2):245-251.
33. Rao RS, Singh S, Sharma BB, Agarwal VV, Singh V. Sildenafil improves six-minute walk distance in chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial. Indian J Chest Dis Allied Sci. 2011;53(2):81-85.
34. Theander K, Jakobsson P, Jörgensen N, Unosson M. Effects of pulmonary rehabilitation on fatigue, functional status and health perceptions in patients with chronic obstructive pulmonary disease: a randomized controlled trial. Clin Rehabil. 2009;23(2):125-136.
35. Hernandes NA, Wouters EF, Meijer K, Annegarn J, Pitta F, Spruit MA. Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J. 2011;38(2):261-267.
36. Dolmage TE, Hill K, Evans RA, Goldstein RS. Has my patient responded? Interpreting clinical measurements such as the 6-minute-walk test. Am J Respir Crit Care Med. 2011;184(6):642-646.
37. Chandra D, Kulkarni HS, Sciurba FC. Learning from the learning effect in the six-minute-walk test [letter]. Am J Respir Crit Care Med. 2012;185(6):684.
38. Spencer LM, Alison JA, McKeough ZJ. Six-minute walk test as an outcome measure: are two six-minute walk tests necessary immediately after pulmonary rehabilitation and at threemonth follow-up? Am J Phys Med Rehabil. 2008;87(3):224-228. (Pubitemid 351301588)
39. Puhan MA, Chandra D, Mosenifar Z, et al National Emphysema Treatment Trial (NETT) Research Group. The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011;37(4):784-790.
40. Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2010;91(2):221-225.
41. Martinez FJ, Foster G, Curtis JL, et al NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med. 2006;173(12):1326-1334. (Pubitemid 43900706)
42. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985;132(8):919-923.
43. Eiser N, Willsher D, Doré CJ. Reliability, repeatability and sensitivity to change of externally and self-paced walking tests in COPD patients. Respir Med. 2003;97(4):407-414. (Pubitemid 36410610)
44. Swinburn CR, Wakefield JM, Jones PW. Performance, ventilation, and oxygen consumption in three different types of exercise test in patients with chronic obstructive lung disease. Thorax. 1985;40(8):581-586. (Pubitemid 15002403)